AEON Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
AEON Biopharma, Inc. (AEON) had Lessee, Operating Lease, Liability, to be Paid, Year One of $307.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $307.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $307.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $297.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $297.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $307.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $307.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $297.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $297.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $297.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $297.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $175.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | $175.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $159.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $213.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $292.00K 10-K/A · filed 2024-05-14 |
| 2023-09-30 | $78.00K 10-Q/A · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |